Old Web
English
Sign In
Acemap
>
Paper
>
HepCom: impact of co-morbidities on the final success of direct antiviral agents therapy in hepatitis C
HepCom: impact of co-morbidities on the final success of direct antiviral agents therapy in hepatitis C
2017
J. Ampuero
C.J. Maté
R. Quiles
N. Palomo
José Miguel Rosales
Susana Llerena
P Cordero
F.J. Serrano
Juan José Urquijo
M. Maraver
G. Ontanilla
A. Ortega
Marta Hernández
Martín Bonacci
Xavier Forns
J.L. Calleja
R.J. Andrade
J.M. Pascasio
M. Diago
M. de la Mata
I. Carmona
B. Figueruela
J. Crespo
J.M. Navarro
M. Buti
J. Salmerón
Manuel Romero-Gómez
Keywords:
Virology
Hepatitis C
Medicine
co morbidity
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]